The Chart of the Day belongs to Marinus Pharmaceuticals (MRNS). I found the pharmaceutical stock by using Barchart to sort today's Top Stocks to Own list first by Weighted Alpha, then by technical buy signals of 80% or more. I always use the Flipchart feature to review the chart for consistent price appreciation. Since the Trend Spotter signaled a buy on 6/21 the stock gained 319.15%.
Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on developing and commercializing therapeutics for the treatment of epilepsy and other targeted neurological, behavioral and psychiatric disorders. The Company offers Ganaxolone which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures. Marinus Pharmaceuticals, Inc. is headquartered in New Haven, Connecticut.
The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
Barchart technical indicators:
- 100% technical buy signals
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 9 new highs and up 103.45% in the last month
- Relative Strength Index 82.96%
- Technical support level at 5.00
- Recently traded at 5.81 with a 50 day moving average of 3.00
Fundamental factors:
- Market Cap $168 million
- Earnings estimated to increase 49.70% this year and an additional 24.30% next year
- The only analyst following the stock rated it a buy
- to The individual investors following the stock on Motley Fool voted that the stock will beat the market
#MRNS
No comments:
Post a Comment